Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
270.00
-2.00 (-0.74%)
Aug 4, 2026, 1:28 PM JST
Wakamoto Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '12 Mar 31, 2012 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
Revenue Revenue Growth | 9,432 | 9,432 | 9,669 | 9,777 | 10,080 | 10,169 |
Revenue Growth | -2.45% | -2.45% | -1.10% | -3.01% | -0.87% | -1.54% |
Gross Profit Gross Profit Growth | 5,080 | 5,080 | 5,176 | 5,680 | 6,227 | 6,622 |
Operating Income Operating Income Growth | -500 | -500 | -756 | -22.89 | 203.52 | 610.25 |
Net Income Net Income Growth | -222 | -222 | -425 | 48.52 | 351.36 | 406.89 |
Earnings Per Share EPS Growth | -6.38 | -6.38 | -12.29 | 1.41 | 10.20 | 12.00 |
EPS Growth | - | - | - | -86.18% | -15.02% | -18.23% |
Revenue by Segment
| Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '12 Mar 31, 2012 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
Prescription drugs Prescription drugs Growth | 5,503 | 5,503 | 5,780 | 6,576 | 6,672 | 6,685 |
OTC Drugs OTC Drugs Growth | 1,951 | 1,951 | 1,905 | - | - | - |
Special Contracts Special Contracts Growth | 1,931 | 1,931 | 1,943 | - | - | - |
Others Others Growth | 48.7 | 48.7 | 85 | 1,111 | 1,268 | 1,247 |
Corporate Corporate Growth | -1.87 | -1.87 | -45 | -32.24 | -53.23 | -58.21 |
Total Total Growth | 9,433 | 9,433 | 9,668 | 9,777 | 10,080 | 10,169 |
| Fiscal Year | Current | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '12 Mar 31, 2012 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
Cash & Investments Cash & Investments Growth | 1,869 | 1,869 | 1,627 | 1,948 | 2,463 | 3,765 |
Total Debt Total Debt Growth | 1,657 | 1,657 | 1,471 | 1,651 | 29.06 | - |
Net Cash (Debt) Net Cash Growth | 212 | 212 | 156 | 297.54 | 2,434 | 3,765 |
Net Cash Growth | 35.90% | 35.90% | -47.57% | -87.78% | -35.35% | 16.28% |
Net Cash Per Share Net Cash Per Share Growth | 6.09 | 6.09 | 4.51 | 8.65 | 70.66 | 111.06 |
| Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '12 Mar 31, 2012 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
Operating Cash Flow Operating Cash Flow Growth | 589 | 589 | 346 | 489.39 | 824.58 | 894.17 |
Capital Expenditures CapEx Growth | -391 | -391 | -467 | -2,610 | -1,826 | -645.33 |
Free Cash Flow Free Cash Flow Growth | 198 | 198 | -121 | -2,120 | -1,001 | 248.84 |
Free Cash Flow Growth | - | - | - | - | - | -28.23% |
| Fiscal Year | TTM | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '12 Mar 31, 2012 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
Gross Margin | 53.86% | 53.86% | 53.53% | 58.10% | 61.77% | 65.12% |
Operating Margin | -5.30% | -5.30% | -7.82% | -0.23% | 2.02% | 6.00% |
Pretax Margin | -1.36% | -1.36% | -6.47% | 1.44% | 6.03% | 7.05% |
Profit Margin | -2.35% | -2.35% | -4.40% | 0.50% | 3.49% | 4.00% |
FCF Margin | 2.10% | 2.10% | -1.25% | -21.69% | -9.93% | 2.45% |
| Fiscal Year | Current | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
Dividend Per Share Dividend Per Share Growth | 3.000 | - | - | 5.000 | 5.000 | 5.000 |
Dividend Per Share Growth | 16.67% | - | - | 0% | 0% | 0% |
Dividend Yield | 1.11% | - | - | 1.72% | 1.47% | 1.47% |
| Fiscal Year | Current | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 |
PE Ratio | - | - | - | 231.79 | 38.12 | 33.48 |
P/FCF Ratio | 47.80 | 43.41 | - | - | - | 54.74 |
PS Ratio | 1.00 | 0.91 | 0.92 | 1.15 | 1.33 | 1.34 |